company background image
4198

S&S Healthcare Holding TPEX:4198 Stock Report

Last Price

NT$26.00

Market Cap

NT$418.8m

7D

-7.1%

1Y

-22.4%

Updated

28 Sep, 2022

Data

Company Financials
4198 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

4198 Stock Overview

S&S Healthcare Holding Ltd., together with its subsidiaries, primarily focuses on the research and development, manufacture, and sale of medical imaging devices in the United States, Europe, Asia, and internationally.

S&S Healthcare Holding Competitors

Price History & Performance

Summary of all time highs, changes and price drops for S&S Healthcare Holding
Historical stock prices
Current Share PriceNT$26.00
52 Week HighNT$35.10
52 Week LowNT$21.75
Beta0.29
1 Month Change-4.76%
3 Month Change9.47%
1 Year Change-22.39%
3 Year Change15.81%
5 Year Change-86.67%
Change since IPO-97.49%

Recent News & Updates

Apr 22
Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt

Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Shareholder Returns

4198TW Medical EquipmentTW Market
7D-7.1%-6.9%-7.0%
1Y-22.4%-13.0%-19.7%

Return vs Industry: 4198 underperformed the TW Medical Equipment industry which returned -11.5% over the past year.

Return vs Market: 4198 underperformed the TW Market which returned -19% over the past year.

Price Volatility

Is 4198's price volatile compared to industry and market?
4198 volatility
4198 Average Weekly Movement7.0%
Medical Equipment Industry Average Movement5.6%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.3%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 4198 is more volatile than 75% of TW stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 4198's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
1988n/an/ahttps://www.swissray.com

S&S Healthcare Holding Ltd., together with its subsidiaries, primarily focuses on the research and development, manufacture, and sale of medical imaging devices in the United States, Europe, Asia, and internationally. It also develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd.

S&S Healthcare Holding Fundamentals Summary

How do S&S Healthcare Holding's earnings and revenue compare to its market cap?
4198 fundamental statistics
Market CapNT$418.81m
Earnings (TTM)-NT$102.95m
Revenue (TTM)NT$185.39m

2.3x

P/S Ratio

-4.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4198 income statement (TTM)
RevenueNT$185.39m
Cost of RevenueNT$177.29m
Gross ProfitNT$8.10m
Other ExpensesNT$111.05m
Earnings-NT$102.95m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-6.39
Gross Margin4.37%
Net Profit Margin-55.53%
Debt/Equity Ratio221.2%

How did 4198 perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is 4198 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4198?

Other financial metrics that can be useful for relative valuation.

4198 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.4x
Enterprise Value/EBITDA-6.7x
PEG Ration/a

Price to Sales Ratio vs Peers

How does 4198's PS Ratio compare to its peers?

4198 PS Ratio vs Peers
The above table shows the PS ratio for 4198 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average3.5x
3184 MicroBase Technology
5xn/aNT$923.2m
4197 Visgeneer
2.2xn/aNT$316.9m
7595 Pharmigene
5xn/aNT$625.9m
6493 Ttbio
1.6xn/aNT$565.2m
4198 S&S Healthcare Holding
2.3xn/aNT$418.8m

Price-To-Sales vs Peers: 4198 is good value based on its Price-To-Sales Ratio (2.3x) compared to the peer average (3.5x).


Price to Earnings Ratio vs Industry

How does 4198's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

Price-To-Sales vs Industry: 4198 is good value based on its Price-To-Sales Ratio (2.3x) compared to the TW Medical Equipment industry average (2.3x)


Price to Sales Ratio vs Fair Ratio

What is 4198's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4198 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 4198's Price-To-Sales Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 4198 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 4198's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 4198's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is S&S Healthcare Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


2.0%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as S&S Healthcare Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

Past Performance

How has S&S Healthcare Holding performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


35.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4198 is currently unprofitable.

Growing Profit Margin: 4198 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 4198 is unprofitable, but has reduced losses over the past 5 years at a rate of 35.7% per year.

Accelerating Growth: Unable to compare 4198's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4198 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (19%).


Return on Equity

High ROE: 4198 has a negative Return on Equity (-131.28%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is S&S Healthcare Holding's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: 4198's short term assets (NT$250.0M) exceed its short term liabilities (NT$211.3M).

Long Term Liabilities: 4198's short term assets (NT$250.0M) exceed its long term liabilities (NT$172.8M).


Debt to Equity History and Analysis

Debt Level: 4198's net debt to equity ratio (162.8%) is considered high.

Reducing Debt: 4198's debt to equity ratio has increased from 20% to 221.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 4198 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 4198 has less than a year of cash runway if free cash flow continues to grow at historical rates of 34.7% each year.


Discover healthy companies

Dividend

What is S&S Healthcare Holding current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

S&S Healthcare Holding Dividend Yield vs Market
How does S&S Healthcare Holding dividend yield compare to the market?
SegmentDividend Yield
Company (S&S Healthcare Holding)n/a
Market Bottom 25% (TW)2.6%
Market Top 25% (TW)7.1%
Industry Average (Medical Equipment)4.1%
Analyst forecast in 3 Years (S&S Healthcare Holding)n/a

Notable Dividend: Unable to evaluate 4198's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 4198's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 4198's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 4198's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 4198 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.1yrs

Average management tenure


CEO

S&S Healthcare Holding has no CEO, or we have no data on them.


Leadership Team

Experienced Management: 4198's management team is considered experienced (4.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4198?
Owner TypeNumber of SharesOwnership Percentage

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Company Information

S&S Healthcare Holding Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: S&S Healthcare Holding Ltd.
  • Ticker: 4198
  • Exchange: TPEX
  • Founded: 1988
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: NT$418.808m
  • Shares outstanding: 16.11m
  • Website: https://www.swissray.com

Location

  • S&S Healthcare Holding Ltd.
  • No. 85 Xinhu 1st Road
  • 7th Floor
  • Taipei
  • 114
  • Taiwan


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
4198TPEX (Taipei Exchange)YesCommon SharesTWTWDJan 2014

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/28 00:00
End of Day Share Price2022/09/27 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.